Company: Brain+ A/S
Transaction type: Warrant Exercise
Date: October 2023
Amount: 4.2 mDKK
Description of company:
Brain+ is addressing one of the largest healthcare challenges of our time, namely dementia. Currently, A new case of dementia arises somewhere in the world every 3 seconds and globally an estimated 55 million people are living with dementia – and unfortunately, this figure is expected to almost triple to 139 million people by 2050. As we generally live longer and the prevention and treatment of the most common causes of death such as cancer and heart disease are getting more efficient, dementia is expected to become a leading cause of death by 2030 and is already the leading cause of death for women in the UK.